Strong Demand for Triple-TOF 5600 Drives AB Sciex's Q1 Revenue Growth
April 22, 2011
Strong Demand for Triple-TOF 5600 Drives AB Sciex's Q1 Revenue Growth
Core revenues at the company rose at high single-digit rates in the first quarter, driven by strong sales of the Triple-TOF 5600 mass spectrometer and robust demand from the academic, proteomics, and applied markets.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Strong TripleTOF 5600 Sales Drive Mid-Teens Q2 Growth at AB Sciex
July 22, 2011 / ProteoMonitor - Automation, Increased Throughput Key to Moving Mass Spec-Based Proteomics into the Clinic
February 11, 2011 / ProteoMonitor - High-End Mass Spec Sales Drive Double-Digit Q4 Growth at Waters, AB Sciex
January 28, 2011 / ProteoMonitor - Instrument Vendors Focus on UPLC and Triple-Quad, Qual-Quan MS at JP Morgan Conference
January 14, 2011 / ProteoMonitor - Proteomics Expectations Bear Fruit in 2010, But Challenges Remain
January 7, 2011 / ProteoMonitor